Structure-based design of antiviral drug candidates targets SARS-CoV-2 main protease
A team of Chinese scientists has recently developed two novel compounds that inhibit the SARS-CoV-2 main protease (Mpro) and one of them is a good drug candidate for further clinical studies.
Apr 22, 2020
0
195